Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Consilient Health Limited, 5<sup>th</sup> Floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland
Vinorelbine 20 mg soft capsules.
| Pharmaceutical Form |
|---|
|
Soft capsule. An oval-shaped light brown soft capsule, with dimensions of 11.3mm (±1.0mm) x 6.7mm (±1.0mm). |
Each soft capsule contains 20 mg vinorelbine (as tartrate).
Excipient with known effect: Each soft capsule containing 20 mg vinorelbine contains 38.44 mg sorbitol
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Vinorelbine |
Vinorelbine is an antineoplastic drug of the vinca alkaloid family but unlike all the other vinca alkaloids. Vinorelbine inhibits tubulin polymerization and blocks mitosis at G2-M, causing cell death in interphase or at the following mitosis. |
| List of Excipients |
|---|
|
Capsule content: Macrogol 400 Capsule shell: Gelatin |
Carton box containing a PVC/PVDC-Aluminium blister with child-resistant safety paper layer.
Carton box containing an OPA/Aluminium/PVC-Aluminium blister.
Pack size: 1 or 4 blisters containing 1 soft capsule each. Not all pack sizes may be marketed.
Consilient Health Limited, 5th Floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland
PL 24837/0094
17/01/2019
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
